PF260 PROGNOSTIC AND PREDICTIVE IMPACT OF NPM1/FLT3-ITD GENOTYPES AS DEFINED BY 2017 EUROPEAN LEUKEMIANET RISK CATEGORIZATION FROM AML PATIENTS TREATED WITHIN THE INTERNATIONAL RATIFY STUDY

Autor:	Martin S. Tallman, K M Laumann, Richard M. Stone, Hartmut Döhner, Guido Marcucci, Rebecca B. Klisovic, J. Nomdedeu, Hubert Serve, B. Axel, Insa Gathmann, Agnes Gambietz, Bruno C. Medeiros, Francesco Lo-Coco, Christian Thiede, Joseph Brandwein, Nikolaus Jahn, Jurjen Jansen, Frederick R. Appelbaum, Gerhard Ehninger, Thomas W. Prior, Richard A. Larson, A. Ganser, Sumithra J. Mandrekar, Jürgen Krauter, Celine Pallaud, Dan Jones, Richard F. Schlenk, Susan Geyer, Jordi Sierra, T. de Witte, H. Michael, S. Amadori, Konstanze Döhner, Tiziana Ottone, Andrew H. Wei, Clara D. Bloomfield, P. Ekaterina, Dietger Niederwieser, Miguel A. Sanz, Lucas J. Huebner
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty NPM1 European LeukemiaNet business.industry Internal medicine Genotype medicine Hematology Risk categorization business Flt3 itd
Zdroj:	HemaSphere. 3:81-82
ISSN:	2572-9241
DOI:	10.1097/01.hs9.0000559252.96061.3e
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::01dfe08510aae81441cb01c0164411a1 https://doi.org/10.1097/01.hs9.0000559252.96061.3e Zobrazit plný text záznamu Plný text